DYN

Dyne Therapeutics Inc (DYN)

US
$ 13.69-2.98%

Price Chart

Key Statistics

Market Cap
$ 986.63M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
1.88M
52W High
$ 47.45
52W Low
$ 6.36
Dividend Yield
0.00%
Beta
1.16

Technicals

50-Day MA
11.7343
200-Day MA
19.5864
52 Week High
47.45
52 Week Low
6.36

About DYN

Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.

Employees
192
Headquarters
Waltham, MA
CEO
Mr. John G. Cox M.B.A.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg